Novartis today announced that it has entered into a development and licensing agreement with Biological E Limited (BioE), a biopharmaceutical company based in India, for two vaccines to protect against typhoid and paratyphoid fevers. The agreement advances the Novartis goal to deliver accessible and affordable vaccines that address unmet medical need in endemic regions.
The Proceedings of the 10th International Rotavirus Sympoisum can be accessed by clicking the link above (best viewed with Internet Explorer).
Printed copies can be obtained on request by emailing firstname.lastname@example.org
Ciro de Quadros is mentioned in PATH's Rotavirus Vaccine Update.
Guest column from Ciro de Quadros in AllAfrica.
New Association Seeks To Support Immunization Managers to Achieve Vaccination Goals
Tremendous gains have been made in immunizations over the last 40 years. Smallpox has been eradicated, poliomyelitis eradication is in sight and progress is being made in measles control. Global immunization coverage for basic vaccines is at its highest, and new vaccines are being added to immunization systems. However, challenges remain and will increase in complexity as new vaccines are added to immunization programs.
IAIM has a governing body known as the Governing Council, which is composed of individuals from all parts of the world who are either current immunization managers or who have relevant leadership experience in immunizations. The following individuals are the members of the association’s first Governing Council (known as the ad hoc Governing Council):